Loading advertisement
Logo
  • Shop Now
  • Help
  • Handicapping & PPs
  • Entries
  • Results
  • News & Info
  • Royal Ascot
  • Breeding
  • Harness
  • Help
  • Shop
  • DRF en Español
  • DRF Recommends
  • Bet on Sports
  • DRF Pro Services
  • DRF Form Finder
Track Pages
Horse Racing News
Stakes Races
DRF TV
Race of the Day
International Racing
Beyer Speed Figures
DRF En Espanol
Hawthorne

Drug positive at Hawthorne

Marcus Hersh|Nov 11, 2005

Donald Paulik, a trainer on the Chicago circuit, has been ruled off all facilities under the jurisdiction of the Illinois Racing Board after one of his horses tested positive for the powerful synthetic narcotic etorphine. The horse that triggered the positive test, Texas Tree, won the first race on Friday, Oct. 21 at Hawthorne. An inquiry into the matter has been scheduled for Saturday, Nov. 19, at which time a penalty could be handed down for the offense.

Paulik, 59, has started only 13 horses all year, winning twice. He trains off a farm, shipping horses to the racetrack only for published workouts and races.

Etorphine, sometimes referred to as elephant juice, is a powerful synthetic relation of morphine. Administered in small doses, it can have a stimulant effect on horses.

DRF Headlines

View All 
Stay Updated Now

Get the latest racing news, expert picks, and exclusive analysis delivered to your inbox.

Sign Up for Newsletter

Interested in News?

Google News

Download DRF app on your smartphone.

Download appDownload app

Events

  • Royal Ascot
  • Hong Kong
  • More

News

  • Race of the Day
  • Track Pages
  • Latest News
  • Breeding
  • More

Tracks

  • Belmont at the
Big A
  • Churchill Downs
  • Gulfstream Park
  • Laurel Park
  • Woodbine

Handicapping & PPs

  • DRF Classic PPs
  • Formulator PPs
  • TimeformUS PPs
  • Daily Racing
Program
  • DRF Picks
  • More
Drf en espanolPurchase ppspreference center
Drf en espanolPurchase ppspreference center

© 2026 Daily Racing Form.  All rights reserved.

Careers
Help
Terms
Privacy

© 2026 Daily Racing Form.  All rights reserved.